The multinational company Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) has expanded its global footprint by making its first-ever cannabis shipment to Switzerland.
The company announced on Tuesday that its Swiss distribution partner Astrasana Holding AG had received the shipment containing medical cannabis extracts.
Clever Leaves and Astrasana are now planning to further expand distribution of the extracts into the Czech Republic as well. Astrasana has a medical cannabis pharmacy and pharmaceutical operations there.
“Clever Leaves’ first commercial shipment of medical cannabis extracts to Astrasana in Switzerland marks a significant step towards our goal of expanding patient access to high-quality medical cannabis across Europe and beyond,” said Andres Fajardo, CEO and Co-Founder of Clever Leaves.
“The supply agreement guarantees Astrasana a reliable and consistent supply of medical cannabis extracts at competitive prices, providing planning certainty and allowing for seamless operations,” said Astrasana’s CEO Yves Antoniazzi.
🧵1/2 Thanks to the hard work of our team and the #quality of our products, we at $CLVR are proud to announce the arrival of our first shipment of high #CBD and high #THC standardized extracts from #Colombia to #Switzerland based partner, Astrasana. pic.twitter.com/0jyKYq543G
— Clever Leaves (@clever_leaves) May 30, 2023
Read more: Clever Leaves sends first cannabis shipment to Portugal
Read more: Switzerland approves more adult-use cannabis pilot projects
Swiss authorities recently approved a cannabis pilot project assessing the health and social impacts of pot sales that will be led by the universities of Bern and Lucerne. The Czech Republic is planning to regulate adult-use cannabis and is currently in the process of drafting an applicable bill to do so.
Clever Leaves also recently completed its first cannabis shipment to Portugal containing EU-GMP-certified CBD extracts that were received by SOMAÍ Pharmaceuticals.
In mid-May, Clever Leaves received GMP certification from authorities in Brazil enabling the company to distribute medical cannabis in the country.
In addition to its Swiss headquarters and pharmacy in the Czech Republic, Astrasana also has subsidiaries in Belgium, Germany and Japan.
Clever Leaves’ shares dropped by 1.81 per cent Tuesday to US$0.25 on the Nasdaq Stock Exchange where they have been on a steady decline for the past six months, dropping by 45.65 per cent.
rowan@mugglehead.com
NEWSLETTER
Subscribe to our newsletter
Want the best of alternative investing news including cannabis, psychedelics, technology, and trending industries sent to your inbox?
Sign up to get our stories of the week sent to your inbox.
We will never sell your information or spam you. By entering your email, you are agreeing to our terms of use and understand our privacy policy.
